Related Experiment Videos
Hypoglycaemia and counterregulation during childhood
K Matyka1, M Ford-Adams, D B Dunger
1Department of Child Health, Birmingham Heartlands Hospital, UK.
Hormone Research
|April 30, 2002
Summary
Counterregulatory responses to hypoglycemia are blunted in young children with type 1 diabetes, especially during sleep. Further research is needed to understand nocturnal hypoglycemia
Area of Science:
- Pediatric Endocrinology
- Metabolic Disorders
- Diabetes Mellitus Research
Background:
- Hypoglycemia is common in children with type 1 diabetes mellitus (T1DM).
- Counterregulatory responses to hypoglycemia in this age group are poorly understood, with conflicting study results.
- Nocturnal hypoglycemia's impact on neurocognitive function and cardiac health in T1DM requires further investigation.
Purpose of the Study:
- To investigate counterregulatory hormone responses during nocturnal hypoglycemia in young children with T1DM.
- To evaluate the contribution of nocturnal hypoglycemia to neurocognitive impairments in pediatric T1DM.
- To explore the link between nocturnal hypoglycemia and adverse cardiac events in adolescents and young adults with T1DM.
Main Methods:
- Review of existing studies on counterregulatory responses during spontaneous and induced hypoglycemia.
- Analysis of neurocognitive performance in children with early-onset T1DM and history of severe hypoglycemia.
- Examination of data linking nocturnal hypoglycemia to cardiac arrhythmia and sudden death in young T1DM patients.
Main Results:
- Counterregulatory hormone responses appear blunted during nocturnal hypoglycemia, potentially due to sleep.
- Cognitive deficits are consistently observed in T1DM children, particularly those with early onset or prior severe hypoglycemia.
- Nocturnal hypoglycemia is associated with cardiac arrhythmia and sudden death risk in adolescents and young adults.
Conclusions:
- Nocturnal hypoglycemia poses significant risks in young individuals with type 1 diabetes, including blunted responses and potential cognitive and cardiac issues.
- New technologies like continuous glucose monitoring may facilitate better understanding and management of hypoglycemia in children.
- Intensified insulin therapy with new analogues or CSII could improve care and compliance if hypoglycemia risks are mitigated.